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INVESTIGATIONS of the uptake of intact proteins by tumour cells in vivo have
yielded conflicting results (Busch, Fujiwara and Firszt, 1961; Babson and Win-
nick, 1954; Campbell and Stone, 1957). In this study use was made offluorescent
labelled proteins as in the previous in vitro work (Easty, Yarnell and Andrews,
1964). The results obtained with a variety of tumours are discussed in relation
to the uptake by normal tissues, the access of blood-borne substances to the
tumours, and the detailed localization of protein within normal and tumour
tissues.
MATERIALS AND METHODS
Preparation and Injection offluorescent proteins
Two proteins were used, crystallized bovine plasma albumin (Armour) and
purified diphtheria toxoid (kindly supplied by Dr. C. G. Pope of the Wellcome
Foundation), which were labelled with fluorescein isothiocyanate as in previous
experiments (Easty et al., 1964). The final concentrations of fluorescent proteins
were adjusted to 5 per cent on 0-85 per cent saline. The usual route of injection
was the tail vein of rats and mice, and the jugular vein of hamsters. The intra-
peritoneal as well as the intravenous route of injection was used for mice bearing
ascites tumours. Mice were injected with 05 ml. of the protein solutions,
rats received 2 ml. and hamsters 1 ml. Animals were killed at intervals after
injection varying from several minutes to 4 days, but mostly after 6 hours.
Samples of the liver, kidneys, lung, spleen, inguinal lymph nodes, skin and bone
marrow from the femurs, as well as the tumours were removed for examination.
Preparations of sections
Several methods of processing the tissues after their removal from the animal
were tried. Some samples were frozen using solid C02, ethyl alcohol mixtures
and then sectioned with a freezing microtome. Others were fixed for several
hours in neutralized 4 per cent formaldehyde, then sectioned with a freezing
microtome. The method finally chosen gave the highest resolution with little
loss ofthe fluorescence ofthe injected proteins, and involved fixation with neutra-
lized 4 per cent formaldehyde in 085 per cent saline for 24 hours followed byparaf-
fin-wax embedding, sectioning, and mounting without deparaffinization in D.P.X.
The paraffin-wax, D.P.X. and all solvents used were checked to ensure that they
were free offluorescent contaminants which might stain-the sections. Sections ofPROTEIN UPTAKE BY CELLS IN VIVO
every sample were stained with haematoxylin and eosin for histological examina-
tion. The procedure for fluorescence microscopy and photomicrography were
the same as described previously (Easty et al., 1964).
At least four animals, each bearing the following tumours were used in the
experiments:
Benzopyrene induced sarcomas in CB hooded strain rats.
Spontaneous mammary carcinomas in C+/cbi mice.
Transplanted sarcoma 180 in CB stock mice.
Transplanted sarcoma CB 4460 in CB stock mice.
Transplanted Harding-Passey melanoma in C-/cbi mice.
Transplanted Walker carcinosarcoma in CB stock rats.
Transplanted multiple myeloma ADJ-PC5 in C-/cbi mice.
Transplanted hepatoma in golden hamsters.
Transplanted (subcutaneous) Ehrlich carcinoma in C -/cbi mice.
EL4 ascites tumour in C57/cbi black mice.
Ehrlich ascites carcinoma in C-/cbi mice.
Fisher ascites lymphosarcoma L5178Y in DBA2/cbi mice.
In addition, normal tissues and tumours from uninjected animals were ex-
amined for autofluorescence.
The use oflissamine green to distinguish between well andpoorly vascularized regions
of the tumours
Goldacre and Sylven have described the use of injected solutions of the dye
for this purpose (Goldacre and Sylven, 1962). This procedure was frequently
used to provide a check on the accessibility of different regions of the tumours to
the fluorescent proteins. Animals which had been injected some hours previously
with fluorescent protein solutions were injected intravenously with 0-5-1 ml. of
2 per cent lissamine green solution I an hour before being killed. The regions
of the tumours which cannot readily be reached by bloodborne substances could
easily be differentiated and separated from those which have a good blood supply.
The dye is lost from the tissues during the fixation procedures and cannot be
detected in unstained sections. Any traces of dye left within the sections did
not increase or decrease to any detectable extent the intensity of the fluorescence
of the fluorescent proteins within the tissues, nor was any significant effect on
the tissue autofluorescence detected. This was investigated by injecting equal
quantities of fluorescent proteins into four C- mice of the same age and weight,
and after 8 hours injecting two of them, each 0 5 ml. of 2 per cent lissamine gree
solution 2 an hour before death. Comparison of the fluorescence observed within
comparable organs from both sets of animals revealed no significant differences.
Similar results were obtained with animals not injected with fluorescent protein.
RESULTS
Normal tissues
Extracellular localization.-Examination of sections of tissues removed im-
mediately after injection of fluorescent proteins revealed intense fluorescence in
all blood vessels. After 2-3 hours fluorescence was observed in the endothelium
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of most blood vessels and in the connective tissues. The basement membranes
of epithelia in the skin and kidney cortex were sites of fairly intense fluorescence.
Fluorescence of lower intensity was observed on connective tissue and other
fibres, and in general, greater fluorescence was observed in loose connective tissue
than in more compact, fibrous connective tissue.
The intensity offluorescence ofthe injected proteins within the tissues reached
a maximum between 6 and 12 hours and then decreased steadily until it could no
longer be detected with certainty on the connective tissue after 24-48 hours.
Fluorescent diphtheria toxoid was lost more rapidly than bovine plasma albumin
from the blood vessels and the connective tissues.
Intracellular localization.-Uptake of both the fluorescent proteins was con-
fined to endothelial cells lining the blood vessels, tissue macrophages, adventitial
cells about the blood vessels, reticular cells of the lymphatic and myeloid tissues
and Kupffer cells in the sinuses of the liver (Fig. 1). Occasionally, fluorescence
was observed in small amounts within the proximal tubule cells of the kidney.
Fluorescence was rarely observed within cells which could be identified un-
equivocally as fibrocytes. Within the lymph nodes uptake was confined mainly
to the endothelial cells lining the sinusoids (Fig. 3). There was little uptake by
cells of the germinal centres or in areas occupied by small lymphocytes. Within
the spleen there was small but detectable uptake by some cells in regions between
germinal centres (Fig. 4). Very little uptake was seen in cells of the bone marrow
obtained from femurs, although the interpretation was complicated by an intense
yellow autofluorescence observed within some of the bone marrow cells of animals
not injected.
Tumour tissues
The distribution of fluorescent proteins throughout the tumours 5-6 hours
after intravenous injection was very similar to that of lissamine green I an hour
after injection. It was observed that those regions of the tumours which were
not visibly penetrated by the free dye contained no fluorescent protein on examina-
tion of the sections, and conversely. Since Goldacre and Sylven (1962) have
shown that the regions not readily reached by lissamine green appear at critical
stages in the tumour growth depending on the nature and size of the tumour,
its rate of growth and the type of host, tumour-bearing animals were selected
whose tumours were expected to be reasonably well vascularized throughout.
In general, there was considerable variation in the amount and distribution
of fluorescent protein within different regions of any individual tumour and be-
tween tumours of the same age and type in different animals. This was in marked
contrast to the reproducibility and similarity of distribution of the fluorescent
proteins within comparable normal tissues ofthe hosts. The results obtained with
the tumours are as follows:
Spontaneous mammary carcinomas in C-+ mice.-These tumours varied in
size from about 3 mm. to 15 mm. in diameter. The distribution of lissamine
green showed that many of these had irregular blood supplies, presenting mottled
patterns of dye distribution, which were reflected in the unevenness ofthe fluores-
cent protein distribution. Only those regions which were readily penetrated by
the proteins will be considered here. Apart from absorption of the proteins on
fibrous elements of the stroma there was frequently striking uptake of fluorescent
proteins by numerous macrophages-- surrounding and- interpenetrating the solid
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masses of tumour tissue (Fig. 7). No detectable quantities of fluorescent protein
were seen within the vast majority of carcinoma cells, not even within those
directly in contact with the surrounding stroma.
Benzopyrene-induced sarcomas in CB hooded rats.-These tumours varied in
size from about 5 mm. to 20 mm. in diameter. Most of them contained necrotic
regions within their interior, and some of the peripheral areas which appeared
to contain healthy cells on histological examination were poorly penetrated by
lissamine green. These observations were consistent with the relatively slight
penetration of fluorescent proteins within the tumour. Uptake of proteins was
confined to a few scattered cells near the periphery of the tumours, judged to be
macrophages. Some binding of fluorescent proteins on fibrous components of
the tumour was also observed.
Transplanted sarcoma 180, myeloma ADJ-PC5, sarcoma CB 4460, Harding
Passey melanoma in mice, and the Walker carcinosarcoma in rats.-The penetra-
tion of lissamine green and fluorescent proteins into these tumours revealed that
most of them contained areas which were very poorly vascularized. There
was considerable absorption of fluorescent proteins on fibres within some of the
tumours (Fig. 5). Comparison of the fluorescent sections with those stained with
Van Gieson's stain and for reticulin revealed that most of the fibres which had
absorbed the fluorescent protein were reticular.
Occasionally, protein uptake was observed in cells lining the sinuses. These
cells were different in appearance from the surrounding tumour cells and were most
probably histiocytes. No detectable uptake of proteins by tumour cells was
observed, even by those which were surrounded by fibres which had absorbed
fluorescent proteins. Considerable uptake of fluorescent protein by fibrous com-
ponents of the loose connective tissue surrounding these tumours was observed.
This connective tissue contained numerous macrophages which had phagocytosed
large quantities of fluorescent protein (Fig. 6). Tumour cells on the periphery of
the tumour, in contact with the fluorescent macrophages and connective tissue
fibres, did not contain detectable quantities of fluorescent protein (Fig. 5, 6).
Transplanted hepatoma in golden hamsters.-The sinusoids of regions of these
tumours were filled with brilliantly fluorescent protein which had also penetrated
between and outlined many individual tumour cells (Fig. 9, 10). Although the
tumour cells were in intimate contact with fluorescent proteins no significant
uptake of the proteins by the tumour cells was detectable.
Comparison of the fluorescent sections with those stained with van Gieson's
stain and for reticulin revealed the almost complete absence ofcollagen or reticulin
from the interior of these tumours. The fluorescent proteins had most probably
leaked from the sinuses which were lined with tumour cells and permeated between
the loosely packed tumour cells.
Solid Ehrlich carcinoma in mice.-These were obtained both as subcutaneous
implants, and as solid tumours which had arisen in the peritoneal body wall and
the diaphragm as a result of the invasion and proliferation of carcinoma cells from
the peritoneum. Some of these mice were injected intravenously and others
intraperitoneally with solutions of the fluorescent proteins. The subcutaneous
implants gave results similar to those obtained with subcutaneous implants of
other mouse tumours, such as sarcoma 180. It was observed that where the
ascites tumours had invaded the diaphragm and peritoneal body wall and had
commenced to infiltrate muscle extensively there were frequent patches of cells
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which had incorporated fluorescent protein. Most of these cells were judged on
examination of adjacent H. and E. sections to consist of macrophages.
Ascites tumours: EL4, Fisher lymphosarcoma and Ehrlich carcinoma in mice.-
Animals bearing these tumours 8-10 days after inoculation were injected intra-
peritoneally or intravenously with fluorescent protein solutions. A considerable
proportion of the fluorescent protein was retained within the peritoneal cavity
EXPLANATION OF PLATES
All the figures are fluorescent photomicrographs.
FIG. 1.-Portion of the liver of a mouse bearing a transplanted sarcoma 180, 5 hours after the
the intravenous injection of 0-5 ml. of fluorescent diphtheria toxoid, showing fluorescent
droplets within Kupffer cells. x 750.
FIG. 2. Section of striated muscle from the peritoneal body wall from the same animal as
Fig. 1, showing absorption of fluorescent protein by the connective tissue and possibly some
incorporation by macrophages. x 300.
FIG. 3. Section of an inguinal lymph node from the same mouse as Fig. 1, showing uptake of
fluorescent protein mainly confined to endothelial cells lining the sinusoids. x 300.
FIG. 4.-Section of the spleen from the same mouse as Fig. 1, showing some absorption of
fluorescent protein by fibres and slight uptake by phagocytic cells between germinal centres.
x 300.
FIG. 5. Section of the interior of the sarcoma 180 from the same mouse as Fig. 1, showing
strong absorption of fluorescent protein by fibres which were almost certainly reticulin.
The uniform, low intensity autofluorescence ofthe tumour cells is indistinguishable from that
seen in sections of sarcoma 180 from uninjected mice. x 300.
FIG. 6.-Section of the loose connective tissue surrounding the sarcoma 180, illustrated in Fig.
5, showing intense incorporation of fluorescent proteins by many macrophages surrounding
a plexus of vessels. The edge of the tumour is included at the bottom of the figure. x 300.
FIG. 7.-Section of a spontaneous mammary carcinoma from a mouse injected intravenously
6 hours previously with 0 5 ml. of 5 per cent fluorescent bovine plasma albumen. There
is some absorption offluorescent protein on the connective tissue fibres and intense accumula-
tion within numerous macrophages surrounding the nodules of tumour cells. There is no
detectable incorporation of fluorescent protein within the tumour cells. x 300.
FIG. 8.-Section of a solid Ehrlich ascites tumour growing on the diaphragm of a mouse which
had been injected intravenouslv 4 hours previously with fluorescent diphtheria toxoid.
In a few regions where the tumour cells have invaded the muscle, groups ofcells judged to be
normal phagocytes have incorporated the fluorescent protein. x 300.
FIG. 9. Section of a transplanted hepatoma in a golden hamster 5 hours after intrajugular
injection of 0-8 ml. of 5 per cent fluorescent bovine plasma albumen. The sinusoids of the
tumour are filled with fluorescent protein which has also permeated between many of the
hepatoma cells. x 300.
FIG. 10.-A region of the hamster hepatoma, Fig. 9, x 750, showing hepatoma cells outlined
by fluorescent protein. No reticulin and very little collagen was detected in this tumour.
FIG. 11.- Section of a benzopyrene-induced rat sarcoma 6 hours after intravenous injection of
2 ml. of 5 per cent fluorescent bovine plasma albumen, showing small groups of macro-
phages which have incorporated theprotein. The tumour cells have amoderately strong blue
autofluorescence, present also in the tumour cells of uninjected animals. x 300.
FIG. 12. Section of a transplanted myeloma in a mouse 5 hours after intravenous injection
of fluorescent bovine plasma albumen, showing absorption of protein on fibres. x 300.
FIG. 13.-Fisher ascites lymphoma cells from a mouse 24 hours after intraperitoneal injection of
fluorescent diphtheria toxoid. The ascites had been diluted about 100 x to obtain a suitable
concentration of cells, and the ascitic fluid is still detectably fluorescent. One dead cell in
the centre is brilliantly and uniformly stained, and fragments of fluorescent debris have be
come attached to the surfaces of the viable cells, x 1200.
FIG. 14.-Ehrlich ascites tumour cells from a mouse 18 hours after intraperitoneal injection of
fluorescent bovine plasma albumin. The fluid is still strongly fluorescent and four cells can
be seen which have incorporated and concentrated the fluorescent protein. x 300.
FIG. 15. Ehrlich ascites tumour cells from a mouse 5 hours after intraperitoneal injection of
bovine plasma albumen conjugated with " impure " rhodamine R.B. 200. The tumour
cells have been washed with tissue culture medium to remove the fluorescent ascitic fluid.
All cells are strongly and uniformly fluorescent. x 300.BRITISH JOURNAL OF CANCER.
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24-36 hours after intraperitoneal injection. With several animals as much as
possible of the ascites fluid was collected, the cells removed by centrifugation,
and the quantity of fluorescent material retained within the peritoneum was
estimated using a colorimetric method. Twenty-four hours after injection of
the fluorescent proteins 40-70 per cent of the injected material remained within
the peritoneum. The presence of the original injected protein within the ascitic
fluid was confirmed in the case of diphtheria toxoid by the gradual addition of
specific antitoxin to the clear supernate. This resulted in the precipitation of
most of the fluorescent material in the form of a yellow precipitate, presumably
the diphtheria toxoid-antitoxin complex.
Intraperitoneal injection into normal mice of an equal quantity of fluorescent
diphtheria toxoid, diluted to give approximately the same volume of fluid as that
present in the ascites tumour-bearing mice, resulted in the elimination of most
of the fluid from the peritoneum in 24 hours, only 5-10 per cent of the injected
protein remaining.
It was also observed that the normal tissues, such as liver, spleen, etc., of
animals bearing well developed ascites tumours which had received intraperi-
toneal injections of fluorescent proteins, contained only traces of fluorescent
proteins within their phagocytic cells after 24 hours. The same tissues from
normal mice injected intraperitoneally with equal quantities contained almost
as much fluorescent material as those animals injected intravenously.
Although the ascites tumour cells were bathed in relatively high concentrations
of the fluorescent proteins for several days, uptake of the proteins was observed
in only 5-10 per cent of the cells, the remainder being negative (Fig. 13, 14).
This result was obtained with each of the three ascites tumours examined. In
only one experiment was distinct fluorescence observed within all the tumour
cells (Fig. 15). In this experiment a sample of bovine plasma albumin was used
which had been conjugated with a relatively impure sample ofrhodamine RB 200.
The excess free dye had been removed by passage through a column of Sephadex
G50 and contained no dye removable by prolonged dialysis or vacuum dialysis.
A sample of the protein conjugate was extracted exhaustively with ethyl acetate,
and on injection ofthis material the usual result was obtained, i.e. uptake by about
5 per cent of the cells.
DISCUSSION
The uptake of the two fluorescent proteins by cells of those normal tissues
examined was very similar to that observed by other investigators (Kruse and
McMaster, 1949; Schiller, Schayer and Hess, 1952; Gitlin, Landing and Whipple,
1953; Mancini et al., 1962), and was chiefly confined to cells of the reticuloendo-
thelial system. Fluorescent protein was also occasionally seen within proximal
tubule cells ofthe kidney. The proteins were absorbed by connective tissue fibres
and also by the basement membranes of epithelia. The fluorescence reached a
maximum on connective tissue from 5-10 hours after intravenous injection and
then disappeared gradually during the following 24 hours. Fluorescent material
was detected within some cells of the reticuloendothelial system 4 days after
injection, but uptake by fibrocytes was rarely observed. The distribution of
fluorescence in cells and tissues was very similar for diphtheria toxoid and bovine
plasma albumin, although the toxoid appeared to be eliminated more rapidly than
the plasma albumin, in agreement with observations of Masouredis who studied
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the distribution and rate of elimination of 131 diphtheria toxoid in guinea-pigs
(Masouredis, 1960).
The access of blood-borne substances to the tumours is of prime importance
in this type of study. The results obtained from the lissamine green and fluo-
rescentproteininjections were consistent in thatregions ofthe tumours not reached
by lissamine green 2 an hour after intravenous injection were not reached by the
proteins. Only those regions of the tumours which were accessible to the pro-
teins will be considered. In these regions significant amounts of fluorescent
protein could not be detected within the vast majority of cells of any of the tu-
mours examined, although the surrounding connective tissue, tumour stroma,
sinusoids and macrophages near to, or in contact with the tumour cells contained
or had absorbed fluorescent proteins. Relatively large quantities of fluorescent
protein may be localized within the tumour, but it can only be seen in detectable
concentrations in the cells and structures mentioned above, and not within the
tumour cells.
It was frequently observed that in sections of tumours removed from the host
24 hours or more after the intravenous injection of fluorescent protein the fibrous
components of the tumour stroma retained some absorbed fluorescent protein,
whilst fluorescence was no longer detectable on fibres within the well vascularized
normal tissues. A very similar result, due to the binding of lissamine green by
dead cells was observed by Goldacre and Sylven (1962). The binding of fluores-
cent protein by dead cells was also observed in this work, but in general the
fluorescent proteins did not reach the necrotic centres in sufficient quantities
to result in intense staining. The possibility of some selective binding by the
fibres ofthe tumour stroma cannot be completely excluded. Very similar observa-
tions have been recorded by Vassar, Saunders and Culling (1960) who postulated
the specific binding of tetracycline in similar regions of tumours as a result of
polypeptide complex linking or calcium metabolism.
Ofparticular interest was the absence of detectable uptake by 90-95 per cent
of the cells of the three mouse ascites tumours investigated, even though these
cells had been bathed in relatively high concentrations of fluorescent proteins
for 24 hours or more. This result was identical with that obtained with two of
these ascites tumours maintained in vitro (Easty et al., 1964). The protein up-
take by 5-10 per cent of the ascites cells has been discussed in detail (Easty etal.,
1964), and, excluding the absorption of fluorescent proteins by dead cells, three
obvious possibilities were mentioned. Some of the cells which took up the
proteins may have been viable tumour cells which differ strikingly from the
majority in their capacity to pinocytose or phagocytose. Some may have been
phagocytic cells of normal origin, including mesothelial cells which had become
detached from the peritoneal body wall. Lastly, some may have been damaged
tumour cells which had an increased capacity for pinocytosis (Thomason and
Schofield, 1961). Similar observations have been made by Platt (1961), who
found that squamous epithelial cells are stimulated to phagocytose under the
influence of local trauma.
Previous investigations into the uptake of intact proteins by tumour cells
in vitro have yielded conflicting results. Babson and Winnick (1954) found that
whereas the uptake of radioactive amino acid by tumours could be inhibited by
flooding with the nonradioactive isotope, the uptake of plasma protein labelled
with that radioactive amino acid could not, which they interpreted as evidence
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for the uptake ofintact protein by the tumour cells. Busch et al. (1961) also using
proteins labelled with radioactive isotopes found that the specific activity of the
protein within the tumour was higher than that found for the liver and other
normal tissues studied. Campbell and Stone (1957) carried out very similar
experiments on rats bearing azo-dye induced hepatomas, and obtained results
suggesting that the protein was broken down into free amino-acids before being
taken up by the tumour cells. It is difficult to see how allowance could have been
made, using these techniques, for the uptake by normal macrophages and fibrous
components which was frequently encountered in the work reported here. Dur-
ing homogenization of the tumour, desorption of intact labelled proteins from
the tumour stroma could occur. The binding of the labelled proteins by fibres
was not solely dependent on the presence of the label, since Mancini et al. (1962)
obtained identical results using both the directly labelled proteins and fluorescent
antibodies.
Cytological studies of protein uptake by tumour cells have been carried out
by Cohen Beiser and Hsu (1961), using immuno-histochemical techniques. They
observed the uptake of injected proteins by scattered cells of azo-dye induced
hepatomas, but pointed out that the incorporation may have been related to
cell damage incidental to the process of carcinogenesis. Ludford (1929, 1932)
showed that the incorporation of injected trypan blue within the tumours of
animals was confined to cells of the reticuloendothelial system, mainly localized
at the tumour periphery. Ghose, Nairn and Fothergill (1962) obtained results
which conflict with those described in this report. They observed in mouse
ascites tumour cells and in the cells of solid tumours " a substantial amount of
protein conjugate ". These conflicting results may be related to experimental
variables as yet unknown.
It must be emphasized that the results described in this communication do
not show that uptake of macromolecules by the majority of viable tumour cells
cannot occur. The sensitivity of the technique is limited. What does emerge,
however, is that reticuloendothelial cells within the tumour and normal tissues
incorporate the injected proteins very much more rapidly than the tumour cells.
There have been suggestions, e.g. Starbuck and Busch (1962), that the pre-
ferential uptake by tumour cells of macromolecules carrying toxic agents might
be of therapeutic value. If the specificity of action was dependent solely on the
quantities taken into the cells, then from this investigation it would appear that
sacrifice of the reticulo-endothelial system would probably precede death of the
tumour cells. This objection would not apply to attempts to replace " deleted "
macromolecules such as enzymes by means of reagents which were not toxic.
However, little is known of the ultimate fate of macromolecules taken into the
cells within vacuoles by pinocytosis or phagocytosis, and electron microscope
studies (Ryser, Caufield and Aub, 1962; Easton, Goldberg and Green, 1962)
have not, so far, yielded convincing evidence of the escape of intact proteins from
the vacuoles into the cytoplasm.
The use of homologous, as opposed to heterologous proteins may well affect
the uptake of proteins by normal and tumour tissues. For example, Nelson and
Buras (1963) have found that homologous and heterologous red blood cells are
phagocytozed at different rates; the spleen primarily taking up homologous red
cells and the liver primarily taking up heterologous red cells. Similarly, changes
in the physiological condition of the host can have profound effects on the uptake
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ofmacromolecules by the cells ofsome tissues. Respiratory hypoxia, for example,
induces active pinocytosis in rat liver parenchyma cells (Oudea, 1963). The
possession by the injected macromolecules ofproperties such as enzymatic activity
(Potter et al., 1960) or antibody specificity (Pressman and Keighley, 1948) can
also effect the distribution of macromolecules within tissues. These, and other
factors need investigation in any attempts to achieve maximum uptake of macro-
molecules by tumour cells and minimum uptake by normal cells.
SUMMARY
1. The distribution of injected fluorescent-labelled diphtheria toxoid and
bovine plasma albumin in some of the normal tissues and the tumours of tumour-
bearing animals has been investigated. Twelve different tumours were examined.
2. Within the normal tissues examined, uptake of fluourescent proteins was
chiefly confined to cells of the reticuloendothelial system and proximal tubule
cells of the kidney. No uptake by the great majority of the tumour cells was
detected.
3. Relatively large quantities of fluorescent protein were frequently observed
within the tumours, but fluorescence was localized within macrophages and on
the fibres of the tumour stroma. In the absence of stroma the proteins pene-
trated between and outlined the tumour cells without being taken up by the cells
in detectable quantities.
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